One thing is sure...the shorts will eventually make more money by shorting it 20-30 cents on a hourly basis than the longs who hold it for months to sell it ONETIME for $12-$20 ! Stocks like these are shorts dream .
I am long $sgyp though...
So I read that valiant acquired Salix's xifasan for $11B to treat IBS with very less diaherra rate and that xifasan is already very successful in treating IBS.
So what is SGYP's drug speciallity here? Since valiant has already planned to market xifasan , why would some pharma be interested in SGYP drug?
Sorry I am just new here and trying to understand the potential of SGYP lead drug.